ABT vs BRK.B · P/E 25, rev $44.33B vs rev $371.44B
Abbott Laboratories (ABT) versus BRK.B (BRK.B) — a side-by-side from cached financials, not a winner call.
Abbott Laboratories (ABT) is a medical devices company listed on NYSE.
BRK.B (BRK.B) common stock. It is led by Warren Buffett.
Latest reported ABT revenue for 2025-12-31 was $44.33B. Net income was $6.52B. Revenue was up 5.7% from 2024-12-31 to 2025-12-31. ABT currently screens at market cap $154.15B and trailing P/E 24.8.
Latest reported BRK.B revenue for 2025-12-31 was $371.44B. Net income was $66.97B. Revenue was up 616.8% from 2015-12-31 to 2025-12-31. BRK.B currently screens at market cap $0.
ABT currently screens at market cap $154.15B and trailing P/E 24.8. BRK.B currently screens at market cap $0.
Not investment advice. Open the ABT and BRK.B stock pages for the full models.
Not investment advice.